Evaluation of adherence, persistence, and efficacy of treatment with Bempedoic acid in a real-life Italian population.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients under Bempedoic acid treatment
Exclusion Criteria:
* Age \< 18 years o \> 80 years
* Patients who refuse to participate and to sign informed consent
Primary outcome measure(s)
Description of adherence to treatment with Bempedoic acid in a real-life Italian population — 6-12-24-36 months Adherence will be assessed in terms of Medical Possession Ratio (MPR), which is defined as the ratio between the treatment units dispensed during the treatment period and the duration of the treatment period itself.
Description of efficacy of treatment with Bempedoic acid in a real-life Italian population — 6-12-24-36 months Efficacy of treatment will be evaluated as a change in the LDL (deltaLDL) value from the start of treatment (percentage and absolute value).
Description of persistence to treatment with Bempedoic acid in a real-life Italian population — 6-12-24-36 months Persistence will be assessed in terms of therapeutic continuity from the start of treatment to enrollment.
Trial sites (1)
Facility
City
Region
Status
Federico II University of Naples, Department of Advanced Biomedical Sciences
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
